TRACK(S): GEN, TRA
Moderator: Nicholas Namias, MD, MBA, FACS, FCCM, Miami, FL
Co-Moderator: Heather L. Evans, MD, MS, FACS, Seattle, WA
Recent randomized trials have provided data regarding resuscitation techniques, selection of vasoactive medications, and adjuncts such as steroids in the setting of sepsis. These are cutting-edge findings not yet integrated into the Surviving Sepsis Guidelines. Experts will provide a practical approach to the management of a septic patient in 2018. Topics to be covered include: updates to surviving sepsis guidelines, vasopressors, fluids, steroids and adjuncts, and antibiotics.
Presentations and Speakers
Introducation and Surviving Sepsis—Is That All?
Vanessa P. Ho, MD, MPH, FACS, Cleveland, Ohio
Source Control and Role of New Antibiotics for Multi-Drug Resistant Organisms (MDROs)
Tanya L. Zakrison, MD, FACS, FRSCS, MPH, Miami, FL
When Is It Time to Stop the Antibiotics? Is Less More?
Rishi Rattan, MD, Miami, FL
Sepsis Prediction and Outcomes
Haytham M.A. Kaafarani, MD, MPH, FACS, Boston, MA
Heather L. Evans, MD, MS, FACS, Seattle, WA